In toxicologic pathology, “blind slide reading” involves procedures in which the pathologist is unaware of the treatment group status of individual animals during the histologic slide evaluation phase of a toxicologic bioassay.  Blind slide reading continues to be a controversial topic, despite published recommendations on this subject authored by professional societies and governmental regulatory agencies

Dr. Jim Fikes joins Experimental Pathology Laboratories, Inc. (EPL) as a Senior Pathologist and Manager of EPL-Boston, MA.  Dr. Fikes will be responsible for the pathology phases of commercial client’s various toxicology studies to include consultation services, initial histopathology evaluation, pathology peer review, and either participating, organizing, or conducting pathology working groups.  Dr. Fikes has

Dr. Elizabeth Galbreath joins Experimental Pathology Laboratories, Inc. (EPL) as a Senior Pathologist and Manager of EPL-Boston, MA.  In addition, Dr. Galbreath will be available as a Principal Consultant for Aclairo Pharmaceutical Development Group Inc, an EPL company. Dr. Galbreath will be available to integrate with a client’s preclinical study efforts to provide consultation services in